Search research articles
Contact Us
Filters
Showing results (41-50 of 88) with videos related to
Page
of 9
Sort By:
Oncotarget
|
February 13, 2016
Histone acetyltransferase inhibitor CPTH6 preferentially targets lung cancer stem-like cells
Marta Di Martile, Marianna Desideri, Teresa De Luca, et al.
Oncogenesis
|
March 14, 2021
USP19 modulates cancer cell migration and invasion and acts as a novel prognostic marker in patients with early breast cancer
Fabiana Alejandra Rossi, Juliana Haydeé Enriqué Steinberg, Ezequiel Hernán Calvo Roitberg, et al.
Pathologica
|
August 31, 2021
Real-World Data on NGS Diagnostics: a survey from the Italian Society of Pathology (SIAPeC) NGS Network
Antonio Marchetti, Mattia Barbareschi, Massimo Barberis, et al.
Clinical Lung Cancer
|
January 25, 2025
Kirsten Rat Sarcoma Virus Mutations Effect On Tumor Doubling Time And Prognosis Of Solid Dominant Stage I Lung Adenocarcinoma
Riccardo Tajè, Vincenzo Ambrogi, Federico Tacconi, et al.
Journal for Immunotherapy of Cancer
|
April 10, 2020
Melanoma-specific bcl-2 promotes a protumoral M2-like phenotype by tumor-associated macrophages
Marta Di Martile, Valentina Farini, Francesca Maria Consonni, et al.
Oncogenesis
|
February 16, 2020
microRNA-378a-5p iS a novel positive regulator of melanoma progression
Maria Grazia Tupone, Simona D'Aguanno, Marta Di Martile, et al.
Pathologica
|
September 18, 2025
Part III - Post-analytical phase
Simonetta Buglioni, Davide Seminati, Rossella Bruno, et al.
Cancers
|
June 24, 2022
A Real-World Systematic Analysis of Driver Mutations' Prevalence in Early- and Advanced-Stage NSCLC: Implications for Targeted Therapies in the Adjuvant Setting
Irene Terrenato, Cristiana Ercolani, Anna Di Benedetto, et al.
Oncology and Therapy
|
November 28, 2024
A Cross-Sectional Study of Variant Interpretation and Reporting of NGS Data Using Tertiary Analysis Software: Navify<sup>®</sup> Mutation Profiler
Francesco Pepe, Gianluca Russo, Nadia Barraco, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 18, 2025
TP53 co-mutations increase risk of recurrence in EGFR-mutated stage I lung adenocarcinoma
Filippo Tommaso Gallina, Daniele Marinelli, Riccardo Tajè, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 88) with videos related to
Sort By:
Page
of 9
Oncotarget
|
February 13, 2016
Histone acetyltransferase inhibitor CPTH6 preferentially targets lung cancer stem-like cells
Marta Di Martile, Marianna Desideri, Teresa De Luca, et al.
Oncogenesis
|
March 14, 2021
USP19 modulates cancer cell migration and invasion and acts as a novel prognostic marker in patients with early breast cancer
Fabiana Alejandra Rossi, Juliana Haydeé Enriqué Steinberg, Ezequiel Hernán Calvo Roitberg, et al.
Pathologica
|
August 31, 2021
Real-World Data on NGS Diagnostics: a survey from the Italian Society of Pathology (SIAPeC) NGS Network
Antonio Marchetti, Mattia Barbareschi, Massimo Barberis, et al.
Clinical Lung Cancer
|
January 25, 2025
Kirsten Rat Sarcoma Virus Mutations Effect On Tumor Doubling Time And Prognosis Of Solid Dominant Stage I Lung Adenocarcinoma
Riccardo Tajè, Vincenzo Ambrogi, Federico Tacconi, et al.
Journal for Immunotherapy of Cancer
|
April 10, 2020
Melanoma-specific bcl-2 promotes a protumoral M2-like phenotype by tumor-associated macrophages
Marta Di Martile, Valentina Farini, Francesca Maria Consonni, et al.
Oncogenesis
|
February 16, 2020
microRNA-378a-5p iS a novel positive regulator of melanoma progression
Maria Grazia Tupone, Simona D'Aguanno, Marta Di Martile, et al.
Pathologica
|
September 18, 2025
Part III - Post-analytical phase
Simonetta Buglioni, Davide Seminati, Rossella Bruno, et al.
Cancers
|
June 24, 2022
A Real-World Systematic Analysis of Driver Mutations' Prevalence in Early- and Advanced-Stage NSCLC: Implications for Targeted Therapies in the Adjuvant Setting
Irene Terrenato, Cristiana Ercolani, Anna Di Benedetto, et al.
Oncology and Therapy
|
November 28, 2024
A Cross-Sectional Study of Variant Interpretation and Reporting of NGS Data Using Tertiary Analysis Software: Navify<sup>®</sup> Mutation Profiler
Francesco Pepe, Gianluca Russo, Nadia Barraco, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 18, 2025
TP53 co-mutations increase risk of recurrence in EGFR-mutated stage I lung adenocarcinoma
Filippo Tommaso Gallina, Daniele Marinelli, Riccardo Tajè, et al.
Page
of 9